From: Identification of a novel merozoite surface antigen of Plasmodium vivax, PvMSA180
Domains | No. of patient samples (n) | Normalized MFIb | 95% CId | No. of healthy samples (n) | Normalized MFIb | 95% CId | p valuee | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
Positive | Negative | Total (%)a | Positive | Negative | Total (%)c | ||||||
I | 32 | 40 | 72 (44.4) | 1.02 | 33.5–55.9 | 1 | 23 | (22) 95.8 | 0.61 | 79.8–99.3 | p < 0.0001 |
II | 12 | 60 | 72 (16.7) | 0.79 | 9.8–26.9 | 1 | 23 | (22) 95.8 | 0.64 | 79.8–99.3 | p < 0.01 |
III | 29 | 43 | 72 (40.3) | 1.02 | 29.7–51.8 | 1 | 23 | (22) 95.8 | 0.70 | 79.8–99.3 | p < 0.0001 |
IV | 30 | 42 | 72 (41.7) | 0.98 | 30.9–53.2 | 0 | 24 | (24) 100 | 0.64 | 86.2–100 | p < 0.0001 |